1-20 of 512 results for askedby:"Lord Walton of Detchant"
Librarians' tools
- Search time
- 0.251 seconds
- Solr query time
- 0.004 seconds
- Search query
- askedby:"Lord Walton of Detchant"
- We searched for
- tablingMember_ses:304287 OR askingMember_ses:304287
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
To ask Her Majesty’s Government whether appropriate treatment for patients with plasma disorders such as haemophilia and primary immunodeficiency, as provided for under the statutory scheme for branded medicines, will continue to be provided following the review of that scheme by the Department of Health.
To ask Her Majesty’s Government whether appropriate treatment for patients with plasma disorders such as haemophilia and primary immunodeficiency, as provided for under the statutory scheme for branded medicines, will continue to be provided following the review of that scheme by the Department of Health.
We are continuing to consider carefully all the consultation responses. It is important we get these changes right for patients, the National Health Service and industry. We want to look in particular at the impact on small and medium sized businesses, while securing the medicines patients need at a cost which the NHS can afford.
My Lords, is the Minister satisfied that the individuals chosen to assess the nature and significance of the disability of disabled individuals are properly qualified and trained to carry out such assessments, and that in doing so they employ well-defined and reproducible criteria?
My Lords, is the Minister satisfied that the individuals chosen to assess the nature and significance of the disability of disabled individuals are properly qualified and trained to carry out such assessments, and that in doing so they employ well-defined and reproducible criteria?
My Lords, the Government are satisfied that those who carry out the personal independence payment assessments are qualified to do so—and indeed, reports suggest that the assessments are running better than the previous DLA regime.
My Lords, the whiplash phenomenon is thought to occur usually when a vehicle is struck heavily from behind, with the result that the passenger or driver in the vehicle that is hit has a sharp flexion of the neck followed by a sharp hyperextension. If it happens that the individual in question already has disc degeneration in the neck, there is no doubt at all that this may on occasions result in actual damage to the spinal cord with significant physical results. However, in the great majority of so-called whiplash cases, no organic abnormality can be detected. Indeed, there is considerable evidence that some of the claims for whiplash injuries are spurious. Having said that, is it not time yet again for the Government and the medical profession experts in this field to come together to see if they can promulgate some objective means of assessing the significance of these claims?
My Lords, the whiplash phenomenon is thought to occur usually when a vehicle is struck heavily from behind, with the result that the passenger or driver in the vehicle that is hit has a sharp flexion of the neck followed by a sharp hyperextension. If it happens that the individual in question already has disc degeneration in the neck, there is no doubt at all that this may on occasions result in actual damage to the spinal cord with significant physical results. However, in the great majority of so-called whiplash cases, no organic abnormality can be detected. Indeed, there is considerable evidence that some of the claims for whiplash injuries are spurious. Having said that, is it not time yet again for the Government and the medical profession experts in this field to come together to see if they can promulgate some objective means of assessing the significance of these claims?
The noble Lord, with his experience as a neurologist, highlights the complicated nature of this injury and the fact that it is not usually detectable on scans. He also made the point about pre-existing degenerative injury. The effort to achieve some sort of consensus among medical experts has been helped by the MedCo portal. It is remarkable how many of the reports now have a more favourable prognosis than used to be the case before it was introduced.
My Lords, I declare an interest as in 1950 I was elected chairman of the BMA’s Registrars Group, the predecessor of the present Junior Doctors Committee. I express the fervent hope that the current negotiations between the BMA and the Government will quickly be concluded to the satisfaction of both parties. In my view and in the view of many doctors it is a matter of considerable concern that there is a suggestion of further industrial action, which is inimical to the ethos of a caring profession. Will the Minister accept my view that the alleged threat by the Secretary of State to impose a new contract of employment on all junior doctors without agreement is outrageous?
My Lords, I declare an interest as in 1950 I was elected chairman of the BMA’s Registrars Group, the predecessor of the present Junior Doctors Committee. I express the fervent hope that the current negotiations between the BMA and the Government will quickly be concluded to the satisfaction of both parties. In my view and in the view of many doctors it is a matter of considerable concern that there is a suggestion of further industrial action, which is inimical to the ethos of a caring profession. Will the Minister accept my view that the alleged threat by the Secretary of State to impose a new contract of employment on all junior doctors without agreement is outrageous?
My Lords, I think the whole House will agree with the noble Lord that we all very much hope to avoid another strike. The Secretary of State has asked David Dalton, the very distinguished chief executive of Salford Royal—the noble Lord, Lord Turnberg, will know him extremely well—to head up those negotiations with the BMA, and we are very hopeful that a conclusion to this dispute will be reached before there is any more strike action.
My Lords, is the Minister aware that regional airports in the United Kingdom such as Newcastle, which is expanding and becoming much busier, are expressing serious concern about the adverse effect on their activities of the lack of capacity in the south-east? Is the Minister absolutely confident that a new runway will be built, or is this beginning to look increasingly like a figment of the Government’s imagination?
My Lords, is the Minister aware that regional airports in the United Kingdom such as Newcastle, which is expanding and becoming much busier, are expressing serious concern about the adverse effect on their activities of the lack of capacity in the south-east? Is the Minister absolutely confident that a new runway will be built, or is this beginning to look increasingly like a figment of the Government’s imagination?
The Government have made it very clear that we will expand south-east airport capacity. The noble Lord is right to point out that failing to address this will result in a loss of £30 billion to £45 billion to the wider economy. The Government are committed to expansion in the south-east: that decision was made clear on 10 December and we will be reporting back in the summer of next year on the final decision that will be taken on this issue.
My Lords, my former medical colleagues in Newcastle upon Tyne, including several distinguished hepatologists are gravely concerned by the increasing incidence of alcohol- induced liver disease in young people. The problem is that in Newcastle—in the centre of the city and on the quayside—many organisations sell what are called, “cheap shots” with a very high alcohol content. Surely the time has come, yet again for the Government to give urgent consideration to the introduction of a statutory minimum price per unit of alcohol.
My Lords, my former medical colleagues in Newcastle upon Tyne, including several distinguished hepatologists are gravely concerned by the increasing incidence of alcohol- induced liver disease in young people. The problem is that in Newcastle—in the centre of the city and on the quayside—many organisations sell what are called, “cheap shots” with a very high alcohol content. Surely the time has come, yet again for the Government to give urgent consideration to the introduction of a statutory minimum price per unit of alcohol.
My Lords, there are strong arguments for minimum unit pricing. However, other consequences might flow from minimum unit pricing to do with illicit alcohol sales and the fact that the cost of that would fall very heavily on those least able to afford it. As I said earlier, it will continue to be kept under consideration by this Government and we will study with great interest what happens in other countries which are introducing minimum unit pricing.
My Lords, one of the great advantages of the pneumococcal vaccination programme is that it is widely believed that a single injection gives lifelong protection—or at least substantially lifelong protection—against pneumococcal pneumonia and pneumococcal meningitis. Is the Minister satisfied that that is still sufficient?
My Lords, one of the great advantages of the pneumococcal vaccination programme is that it is widely believed that a single injection gives lifelong protection—or at least substantially lifelong protection—against pneumococcal pneumonia and pneumococcal meningitis. Is the Minister satisfied that that is still sufficient?
My Lords, the noble Lord knows far more about this than I do. I can tell him that the PCV 13 vaccination for young children provides long-term protection and, as importantly, prevents the disease spreading. The PPV—the polysaccharide vaccination provided to older people—does not have the longevity of PCV 13, but it provides wider protection against 23 of the serotypes, rather than 13. It does not provide the length of protection that PCV 13 does, but it still provides some protection.
My Lords, is the Minister aware that the poliomyelitis virus attacks the nerve cells in the brain stem and spinal cord which give origin to the nerves that control the movement of the muscles, and, hence, that if these cells are killed, the result is paralysis of the relevant muscles? Several authorities believe that in an acute attack of poliomyelitis, certain nerve cells are damaged but recover, only to die prematurely some years later, thus causing the post-polio syndrome of progressive muscular weakness. Would not one important strategy be to have a graded exercise programme to try to increase the power of those muscles that retain a viable nerve supply?
My Lords, is the Minister aware that the poliomyelitis virus attacks the nerve cells in the brain stem and spinal cord which give origin to the nerves that control the movement of the muscles, and, hence, that if these cells are killed, the result is paralysis of the relevant muscles? Several authorities believe that in an acute attack of poliomyelitis, certain nerve cells are damaged but recover, only to die prematurely some years later, thus causing the post-polio syndrome of progressive muscular weakness. Would not one important strategy be to have a graded exercise programme to try to increase the power of those muscles that retain a viable nerve supply?
The noble Lord is much better informed about this than I am, and of course I agree with him 110%. However, there are other aspects to treating this pernicious illness; clearly pain relief is important. It raises the issue that GP practices having a multidisciplinary team—physios and people who are experts in mobility, orthotics, pain relief and exercise—is very important.
My Lords, I am not the only doctor to have expressed some reservations when the Health and Social Care Act decided to transfer funding for public health from the National Health Service to the local authorities. Do the Government now regret that decision in the light of the problems highlighted in the Question—particularly at a time when public health is facing enormous challenges, not least due to the obesity epidemic and the alarming increase in the incidence of type 2 diabetes?
My Lords, I am not the only doctor to have expressed some reservations when the Health and Social Care Act decided to transfer funding for public health from the National Health Service to the local authorities. Do the Government now regret that decision in the light of the problems highlighted in the Question—particularly at a time when public health is facing enormous challenges, not least due to the obesity epidemic and the alarming increase in the incidence of type 2 diabetes?
My Lords, I am hesitant to disagree with the noble Lord, in view of the fact that he told me earlier that he qualified as a doctor in 1945, which was nine years before I was born. However, the devolution of responsibility to local authorities has been fairly universally welcomed. They are better able to take into account local priorities. I should also add that just over £2 billion of the public health budget is held centrally as well.
My Lords, I declare an interest in that for many years I have been a member of the ALCS—the Authors’ Licensing and Collecting Society—from which I receive minuscule sums about twice a year when people, in their wisdom, decide either to borrow or to photocopy from any of my published works. Many libraries have lost their paid staff and are staffed wholly by volunteers. Can the Minister say whether such libraries are no longer covered by the public lending right so that those authors whose works are photocopied or borrowed from them no longer receive any financial benefit?
My Lords, I declare an interest in that for many years I have been a member of the ALCS—the Authors’ Licensing and Collecting Society—from which I receive minuscule sums about twice a year when people, in their wisdom, decide either to borrow or to photocopy from any of my published works. Many libraries have lost their paid staff and are staffed wholly by volunteers. Can the Minister say whether such libraries are no longer covered by the public lending right so that those authors whose works are photocopied or borrowed from them no longer receive any financial benefit?
My Lords, it is for the local authority to determine how best to provide a comprehensive and efficient library service. Volunteer-supported libraries are considered for public lending right—the point that was at issue—where they are within a library authority’s statutory public library service.
Can the Minister say what qualifications are now required of doctors who are recruited to work in prisons? Can he further say what proportion of those who are now employed to work in prisons have had formal psychiatric training?
Can the Minister say what qualifications are now required of doctors who are recruited to work in prisons? Can he further say what proportion of those who are now employed to work in prisons have had formal psychiatric training?
I thank the noble Lord for that question. I hope he will think it acceptable if I reply to him in writing after this session.
Is the Minister aware that, in 2000, your Lordships’ Select Committee on Science and Technology, of which I was then a member, conducted a major investigation into the potential medical benefits of cannabis preparations and cannabis itself. We were satisfied that smoking cannabis was just as dangerous in causing cancer as smoking tobacco, if not more so. Nevertheless, we received substantial anecdotal evidence of benefits from cannabis ingestion in a variety of medical conditions. Subsequently, a company called GW Pharmaceuticals produced a wholly standardised cannabis-based preparation. That was subjected to some very convincing clinical trials which led to it being licensed by the MHRA in 2010 for the treatment of spasms and spasticity in multiple sclerosis. That is now the case, but the evidence is growing that various cannabinoids may also be of benefit. Would not the reschedule recommended by my noble friend Lady Meacher help to expedite additional trials and lead to the beneficial effects of cannabis being more available for medical conditions?
Is the Minister aware that, in 2000, your Lordships’ Select Committee on Science and Technology, of which I was then a member, conducted a major investigation into the potential medical benefits of cannabis preparations and cannabis itself. We were satisfied that smoking cannabis was just as dangerous in causing cancer as smoking tobacco, if not more so. Nevertheless, we received substantial anecdotal evidence of benefits from cannabis ingestion in a variety of medical conditions. Subsequently, a company called GW Pharmaceuticals produced a wholly standardised cannabis-based preparation. That was subjected to some very convincing clinical trials which led to it being licensed by the MHRA in 2010 for the treatment of spasms and spasticity in multiple sclerosis. That is now the case, but the evidence is growing that various cannabinoids may also be of benefit. Would not the reschedule recommended by my noble friend Lady Meacher help to expedite additional trials and lead to the beneficial effects of cannabis being more available for medical conditions?
The noble Lord is absolutely right in tracing this back to a long debate in the Select Committee, the work of which I pay tribute to. That was, of course, taken into account in the MHRA’s decision. Should there be new drugs of this classification which have proven benefits for patients, they should, of course, make an application and undergo clinical trials in the same way.
Would the Minister accept that NICE is faced with an extremely difficult problem in continually having to consider the efficacy and affordability of new cancer drugs as they emerge in a National Health Service under financial constraint? Would he also accept that another major problem is emerging in relation to the orphan and ultra-orphan drugs now coming on stream for the treatment of rare diseases, which are equally deserving in many respects? How does he feel that the next Government—however they are constituted—will be able to consider this increasingly serious problem?
Would the Minister accept that NICE is faced with an extremely difficult problem in continually having to consider the efficacy and affordability of new cancer drugs as they emerge in a National Health Service under financial constraint? Would he also accept that another major problem is emerging in relation to the orphan and ultra-orphan drugs now coming on stream for the treatment of rare diseases, which are equally deserving in many respects? How does he feel that the next Government—however they are constituted—will be able to consider this increasingly serious problem?
My Lords, the noble Lord is right that there is a particular issue around the appraisal of new cancer drugs. That is why NHS England, the Department of Health, cancer charities, NICE and the Ethical Medicines Industry Group, as well as the ABPI, are working together currently as part of a new working party tasked with finding the best way to get new cancer drugs appraised and commissioned for patients. A number of proposals have been looked at to reach an integrated process between NHS England and NICE which results in clear and final decisions on baseline commissioning of chemotherapy drugs.
My Lords, in light of the alarming increase in type 2 diabetes, which is closely related to the incidence of obesity, what advice are the Government giving to the population at large about the dangers of overeating? When I was in clinical practice I used to advise my overweight patients to take a large dose of will power three times a day with meals.
My Lords, in light of the alarming increase in type 2 diabetes, which is closely related to the incidence of obesity, what advice are the Government giving to the population at large about the dangers of overeating? When I was in clinical practice I used to advise my overweight patients to take a large dose of will power three times a day with meals.
My Lords, the noble Lord very eloquently makes an important point. There is no simple answer to the problem of obesity: it is multifactorial. However, in recognising that we need to communicate our messages to health experts and, indeed, members of the public—which is his central point—my department and Public Health England are leading work with a group of experts to consider how to make the Chief Medical Officer’s guidelines easier to communicate to health professionals and the public. That work is progressing well, but we do need to progress it.
To ask Her Majesty’s Government why the acute adult dermatology service at Nottingham University Hospital is to be closed; and whether they have assessed the effect that that decision will have upon patients in the area affected by skin diseases.
To ask Her Majesty’s Government why the acute adult dermatology service at Nottingham University Hospital is to be closed; and whether they have assessed the effect that that decision will have upon patients in the area affected by skin diseases.
The provision of services, including dermatology services, is a matter for the local National Health Service.
The NHS Trust Development Authority advises that since 2 February 2015 Nottingham University Hospital NHS Trust has not been able to provide a comprehensive adult dermatology service. It no longer has sufficient consultant dermatologist capacity to sustain such a service.
The Trust has worked with commissioners to ensure a satisfactory service is available to local people from alternative providers.
Rushcliffe Clinical Commissioning Group has commissioned a review to assess what is needed to meet the needs of the population in the future.
To ask Her Majesty’s Government what effect they consider the loss of six consultant dermatologists in Nottingham will have upon direct services to the local community and the training of junior doctors and medical students.
To ask Her Majesty’s Government what effect they consider the loss of six consultant dermatologists in Nottingham will have upon direct services to the local community and the training of junior doctors and medical students.
This Government established Health Education England to co-ordinate education and training activity across the National Health Service, including the management of training programmes for junior doctors. Health Education England and the Local Education and Training Board in the East Midlands are best placed to work with local employers in Nottingham to understand and manage the impact of changes.
My Lords, in the course of my career in neurology I have treated many patients with epilepsy at all ages and in all its variants. There is no doubt that there has been a remarkable transformation in the management of all the types of this condition as a result of research in our universities and in the pharmaceutical industry. Nevertheless, there are still some patients in whom seizures are intractable and do not respond effectively even to the most modern drugs. Quite apart from what the Neurological Alliance has said, is the Minister aware that the Association of British Neurologists has identified a striking unevenness in the quality and availability of specialised neurological care throughout the country? What are the Government doing to make certain that these facilities, which are so necessary in treating this condition, are more properly and evenly distributed?
My Lords, in the course of my career in neurology I have treated many patients with epilepsy at all ages and in all its variants. There is no doubt that there has been a remarkable transformation in the management of all the types of this condition as a result of research in our universities and in the pharmaceutical industry. Nevertheless, there are still some patients in whom seizures are intractable and do not respond effectively even to the most modern drugs. Quite apart from what the Neurological Alliance has said, is the Minister aware that the Association of British Neurologists has identified a striking unevenness in the quality and availability of specialised neurological care throughout the country? What are the Government doing to make certain that these facilities, which are so necessary in treating this condition, are more properly and evenly distributed?
There are four such facilities in the UK: one in Bristol, Alder Hey in Liverpool, one in London and, I am sorry, I have forgotten offhand the fourth. The Government certainly are on to this and are sympathetic to the comments that the noble Lord has made.
My Lords, would the Minister accept that the Select Committee structure is one of the great strengths of this House? I served for many years on the Science and Technology Select Committee and had the privilege of chairing several sub-committee inquiries. One of those, relating to research in the NHS, led to the Culyer report, then to the establishment of the National Institute for Health Research and now has led on to the development of the massive Crick centre for research in the centre of London. Can the Minister give us any inkling as to the extent to which Select Committee reports in this House have led to major changes in government policy over the last few years?
My Lords, would the Minister accept that the Select Committee structure is one of the great strengths of this House? I served for many years on the Science and Technology Select Committee and had the privilege of chairing several sub-committee inquiries. One of those, relating to research in the NHS, led to the Culyer report, then to the establishment of the National Institute for Health Research and now has led on to the development of the massive Crick centre for research in the centre of London. Can the Minister give us any inkling as to the extent to which Select Committee reports in this House have led to major changes in government policy over the last few years?
As the noble Lord knows from the exchange he and I had last week in the debate about the effectiveness of this House, I acknowledged then his strong point that the work of Select Committees in this House is an incredibly important part of our work here. On the Science and Technology Committee, during this Parliament there has been some action by the Government in response to implementing long-term science capital investment, which was a recommendation that came out of that committee.
To ask Her Majesty’s Government how they propose to respond to the survey of Acute Neurology Services issued by the Association of British Neurologists in December; and what action they plan to take to ensure that clearly defined quality standards in acute neurology are achieved evenly throughout the United Kingdom...
To ask Her Majesty’s Government how they propose to respond to the survey of Acute Neurology Services issued by the Association of British Neurologists in December; and what action they plan to take to ensure that clearly defined quality standards in acute neurology are achieved evenly throughout the United Kingdom...
NHS England recognises that, as this report from the Association of British Neurologists (ABN) shows, there is room for improvement in the way neurology services are delivered in acute settings. It has been working with the ABN, the Neurological Alliance, the National Clinical Director for Neurological Conditions and representatives from the Strategic Clinical Networks to develop a framework for improving neurology standards within acute settings.
The aim of this framework, which is in the process of being developed, is to help patients and their carers understand what standard of care they should expect, and to support clinicians, National Health Service staff, commissioners and others in the NHS and elsewhere that are responsible for the care of people with neurological conditions to understand how Acute services can be better delivered.
Neurological care in Wales, Scotland and Northern Ireland is matter for the devolved administrations of those countries.
To ask Her Majesty’s Government whether they will publish a report on the work of the Rare Diseases Advisory Group, indicating the extent to which its recommendations have influenced the decisions of the National Institute for Health and Care Excellence and NHS England.
To ask Her Majesty’s Government whether they will publish a report on the work of the Rare Diseases Advisory Group, indicating the extent to which its recommendations have influenced the decisions of the National Institute for Health and Care Excellence and NHS England.
The Rare Diseases Advisory Group (RDAG) was established by NHS England to provide it and the devolved administrations of Scotland, Wales and Northern Ireland with consistent advice on developing and implementing the strategy for rare diseases and highly specialised services. The RDAG is directly accountable to the NHS England Clinical Priorities Advisory Group. The group’s terms of reference state that the agendas and minutes from their meetings are available on the NHS England website. The Department has no plans to publish any further reports on RDAG’s work.
The National Institute for Health and Care Excellence (NICE) develops its guidance independently, based on the available evidence and in consultation with stakeholders. NICE is a full member of RDAG. NHS England is a stakeholder in all NICE’s highly specialised technology guidance and may seek advice from the RDAG in engaging with NICE’s guidance development processes.